<p>Ascletis Pharma Inc. has filed a next day disclosure return to the Hong Kong Stock Exchange, reporting the repurchase of 200,000 shares at an aggregate price of HKD 2,609,890. The repurchased shares will be cancelled. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascletis Pharma Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251216-11957599), on December 16, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)</p>

01672

<p>Ascletis Pharma Inc. repurchased 200,000 shares for HKD 2.61 million, as disclosed in a filing to the Hong Kong Stock Exchange. The shares will be cancelled.</p>

Ascletis Pharma Repurchases 200,000 Shares for HKD 2.61 Million in HKEX Filing